BioSpace News Archive

Drug Development

Immix Approved to Begin Phase I/IIa Study of Flagship Candidate

Immix Biopharma is proud to announce it has received Human Research Ethics Committee (IRB) approval to begin a Phase 1/2a Open-Label, Dose-Escalation/Dose-Expansion Safety, Tolerability and Pharmacokinetic Study of IMX-110 in Participants with Advanced Solid Tumors.

January 5, 2018
·
3 min read
Drug Development

Xencor Announces 2018 Priorities and Expected Milestones

The Company’s expected clinical development and research milestones are outlined.

January 5, 2018
·
7 min read
Biotech Beach

Sensifree Reports Statistically Significant Concordance of Arterial Pressure Signal Waveform Between its Continuous Non-invasive Blood Pressure Monitoring Technology and Invasive Arterial Line

Preliminary results demonstrate accurate tracking of systolic and diastolic pressure values.

January 5, 2018
·
2 min read
Drug Development

Potenza Therapeutics Unveils Pipeline of Immuno-Oncology Programs

Potenza provided insights into its portfolio of immuno-oncology therapies that turn on or off the signaling mechanisms that control a patients‘ own immune system to recognize and destroy cancer.

January 5, 2018
·
3 min read
Propanc Biopharma Repays Magna Invests Senior Secured Convertible Debentures

Propanc Biopharma today announced that the Company has repaid in full all outstanding debt to Magna Invests.

January 5, 2018
·
4 min read
Drug Development

ViaCyte Announces First Patients Implanted in Cohort 2 with Potentially Efficacious Dose of PEC-Direct Islet Cell Replacement Therapy

This novel cell replacement therapy is being developed as a potential functional cure for patients with type 1 diabetes who are at high risk for acute life-threatening complications.

January 5, 2018
·
5 min read
Business

Dynatronics Announces Distribution Agreement With Orthopedic Outfitters

Dynatronics today announced a new distribution agreement for the Company’s Dynatronics division’s products with Orthopedic Outfitters.

January 5, 2018
·
2 min read
Business

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, January 31, 2018

Thermo Fisher Scientific announced that it will release its financial results for the 2017 fourth quarter and full year before the market opens on Wednesday, January 31, 2018, and will hold a conference call on the same day at 8:30 a.m. EDT.

January 5, 2018
·
1 min read
Business

Obalon Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Full Year 2017

For the full year 2017, total preliminary, unaudited revenue is expected to be $10.1 million, an estimated increase of approximately 200% over 2016.

January 5, 2018
·
4 min read
Lone Star Bio

Molecular Templates Provides Corporate Update and Outlines 2018 Milestones

A look at the past year and what’s in store for Molecular Templates in 2018.

January 5, 2018
·
4 min read